Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

PRAX Praxis Precision Medicines Inc

76,26

-0,74 (-0,96%)

31 Déc 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/14/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lauren M Mastrocola

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Praxis Precision Medicines (NASDAQ:PRAX)
Graphique Historique de l'Action
De Déc 2024 à Déc 2024

Plus de graphiques de la Bourse Praxis Precision Medicines

Praxis Precision Medicines (NASDAQ:PRAX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Praxis Precision Medicines

Actualités Praxis Precision Medicines Inc

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Lundi 23 Décembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 20 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 16 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 16 Novembre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 14 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Vendredi 8 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mercredi 6 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mercredi 6 Novembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 15 Octobre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur Praxis Precision Medicines Inc

Societe Generale Effekten

VanEck Semiconductor ETF

Vontobel Financial Produ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales